These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

574 related articles for article (PubMed ID: 25501184)

  • 1. Role of Th1/Th2 cytokines in serum on the pathogenesis of chronic hepatitis C and the outcome of interferon therapy.
    Zhang L; Hao CQ; Miao L; Dou XG
    Genet Mol Res; 2014 Nov; 13(4):9747-55. PubMed ID: 25501184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cytokine levels in serum of patients with chronic hepatitis C and its significance].
    Zhang L; Miao L; Han F; Dou XG
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Mar; 27(3):301-3. PubMed ID: 21419051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study on the relationship between the serum levels of Th1/Th2 cytokines and the clinical manifestations of chronic hepatitis C and the outcome of interferon therapy].
    Zhang L; Miao L; Liu JF; Fu HC; Ma L; Zhao GZ; Dou XG
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Oct; 23(5):352-4. PubMed ID: 20387484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Schistosoma mansoni co-infection on serum profile of interferon-gamma, interleukin-4 and interleukin-10 in patients with chronic hepatitis C virus infection.
    Emam EA; Emam M; Shehata AE; Emara M
    Egypt J Immunol; 2006; 13(2):33-40. PubMed ID: 18689269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T helper type 1/T helper type 17-related cytokines in chronic hepatitis C patients before and after interferon and ribavirin therapy.
    Fathy A; Ahmed AS; Metwally L; Hassan A
    Med Princ Pract; 2011; 20(4):345-9. PubMed ID: 21576995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helper T cell cytokine response to ribavirin priming before combined treatment with interferon alpha and ribavirin for patients with chronic hepatitis C.
    Furusyo N; Kubo N; Toyoda K; Takeoka H; Nabeshima S; Murata M; Nakamuta M; Hayashi J
    Antiviral Res; 2005 Jul; 67(1):46-54. PubMed ID: 15913800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-12 p40/p70 ratio and in vivo responsiveness to IFN-alpha treatment in chronic hepatitis C.
    Piazzolla G; Tortorella C; Fiore G; Fanelli M; Pisconti A; Antonaci S
    J Interferon Cytokine Res; 2001 Jul; 21(7):453-61. PubMed ID: 11506737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoregulatory cytokines in chronic hepatitis C virus infection: pre- and posttreatment with interferon alfa.
    Cacciarelli TV; Martinez OM; Gish RG; Villanueva JC; Krams SM
    Hepatology; 1996 Jul; 24(1):6-9. PubMed ID: 8707283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum interleukin-6 levels correlate with resistance to treatment of chronic hepatitis C infection with pegylated-interferon-α2b plus ribavirin.
    Ueyama M; Nakagawa M; Sakamoto N; Onozuka I; Funaoka Y; Watanabe T; Nitta S; Kiyohashi K; Kitazume A; Murakawa M; Nishimura-Sakurai Y; Sekine-Osajima Y; Itsui Y; Azuma S; Kakinuma S; Watanabe M;
    Antivir Ther; 2011; 16(7):1081-91. PubMed ID: 22024524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid virological response in peripheral blood mononuclear cells with an increase of hepatitis C virus-specific interferon-gamma production predisposes to sustained virological response in patients with chronic hepatitis C genotype 1 undergoing treatment with pegylated-interferon alpha 2a plus ribavirin.
    Perrella A; Sbreglia C; Atripaldi L; Esposito C; D'Antonio A; Perrella O
    Scand J Gastroenterol; 2010; 45(2):250-5. PubMed ID: 19968615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment prediction of virological response to peginterferon plus ribavirin therapy in chronic hepatitis C patients using viral and host factors.
    Shirakawa H; Matsumoto A; Joshita S; Komatsu M; Tanaka N; Umemura T; Ichijo T; Yoshizawa K; Kiyosawa K; Tanaka E;
    Hepatology; 2008 Dec; 48(6):1753-60. PubMed ID: 18925643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proapoptotic IL-18 in patients with chronic hepatitis C treated with pegylated interferon-alpha.
    YingLi H; Shumei L; Qian Y; Tianyan C; Yingren Z; Wei C
    Clin Exp Med; 2009 Jun; 9(2):173-8. PubMed ID: 19238512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.
    Czerwionka-Szaflarska M; Chrobot A; Szaflarska-Szczepanik A
    Med Sci Monit; 2000; 6(5):964-70. PubMed ID: 11208439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulators, sFas and Fas-L as potential noninvasive predictors of IFN treatment in patients with HCV genotype-4.
    Zekri AR; Haleem HA; Esmat GE; Bahnassy AA; El-Din HM; Hafez MM; Sharaby AF; Sharaf H; Zakaria MS
    J Viral Hepat; 2007 Jul; 14(7):468-77. PubMed ID: 17576388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined impact of hepatitis C virus genotype 1 and interleukin-6 and tumor necrosis factor-α polymorphisms on serum levels of pro-inflammatory cytokines in Brazilian HCV-infected patients.
    Tarragô AM; da Costa AG; Pimentel JP; Gomes ST; Freitas FB; Lalwani P; de Araújo AR; Victória Fda S; Victória MB; Vallinoto AC; Sadahiro A; Teixeira-Carvalho A; Martins-Filho OA; Malheiro A
    Hum Immunol; 2014 Nov; 75(11):1075-83. PubMed ID: 25193024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine mRNA expression in hepatitis C virus infection: TH1 predominance in patients with chronic hepatitis C and TH1-TH2 cytokine profile in subjects with self-limited disease.
    Gigi E; Raptopoulou-Gigi M; Kalogeridis A; Masiou S; Orphanou E; Vrettou E; Lalla TH; Sinakos E; Tsapas V
    J Viral Hepat; 2008 Feb; 15(2):145-54. PubMed ID: 18184198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Th1/Th2 type cytokines in hepatitis B patients treated with interferon-alpha.
    Xing T; Zhang L; Lu Q; Hou J; Feng X; Luo K
    Chin Med J (Engl); 2001 Sep; 114(9):921-4. PubMed ID: 11780382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating IL-2 and IL-10 in chronic active hepatitis C with respect to the response to IFN treatment.
    Bozkaya H; Bozdayi AM; Aslan N; Türkay C; Sarioglu M; Cetinkaya H; Akdogan M; Cinar K; Erden E; Köse K; Sentürk H; Akkiz H; Karayalcin S; Yurdaydin C; Uzunalimoglu O
    Infection; 2000 Sep; 28(5):309-13. PubMed ID: 11073139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative analysis of specific Th1/Th2 helper cell responses and IgG subtype antibodies in interferon-alpha-treated patients with chronic hepatitis C.
    Hempel G; Galle PR; Löhr HF
    J Med Virol; 2001 Jul; 64(3):340-9. PubMed ID: 11424124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Th1 and Th2 cytokine profiles induced by hepatitis C virus F protein in peripheral blood mononuclear cells from chronic hepatitis C patients.
    Yue M; Deng X; Zhai X; Xu K; Kong J; Zhang J; Zhou Z; Yu X; Xu X; Liu Y; Zhu D; Zhang Y
    Immunol Lett; 2013 May; 152(2):89-95. PubMed ID: 23680070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.